ST. PETERSBURG, Fla.— InnerCap Technologies Inc. was awarded a U.S. patent (No. 7,670,612), “Multi-phase, multi-compartment capsular delivery apparatus and methods for using same,” a specialty delivery system with application for nutraceutical and medical food products. The patented delivery system enables the development of two-piece capsule-based combination products that have compatibility, formulation or targeted delivery obstacles.
“This is a significant development for InnerCap Technologies’ NOVACAP® technology,” said Fred H. Miller, CEO. “The continued growth of our patent portfolio establishes InnerCap as one of the leading companies in this space. InnerCap’s multi-phase, multi-compartment technology has been commercially manufactured and validated in several products, demonstrating that InnerCap’s delivery system creates real value to consumers and branded manufacturers.”
The delivery system and combinations covered by the patent allow delivery of therapeutic ingredients via oral, implanted or suppository capsules. According to the company, it also substantially improves the efficacy, safety and side-effect profile of certain compounds, and can provide significant quality-of-life improvements for consumers.
